HEPARIN LOCK FLUSH SOLUTION, USP 2 USP UNIT/ 2 ML MIH-4422

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a health professional report with the FDA on 2018-08-24 for HEPARIN LOCK FLUSH SOLUTION, USP 2 USP UNIT/ 2 ML MIH-4422 manufactured by Medefil, Inc..

Event Text Entries

[118872409] Medefil is vigorously investigating this incident and evaluating all potential sources of hair and other potential contamination. Medefil has established numerous manufacturing and inspection controls. All medefil products are manufactured in a controlled environment with a filling enclosure line that is classified as a class 10,000 and a surrounding filling area that is classified as class 100,000. In addition, all of our products undergo terminal sterilization and 100% inspection by an automated eisai inspection system that is validated to inspect for multiple defect types including particles suspended in the solution. Medefil recognizes the risk that this incident poses to the public and is currently evaluating if any further actions are required. We are currently finalizing our traceability assessment to identify all the components used to manufacture batch h218321n. The components potentially involved in this incident are identified as the syringe 6 ml barrel (specification no. C1004ac), syringe tip cap (specification no. C1008-grac), and plunger stopper (specification no. C1009). Based on these components, a list of potentially affected batches is being created.
Patient Sequence No: 1, Text Type: N, H10


[118872410] Medefil received a call from (b)(6) of (b)(6) hospital, (b)(6) on (b)(6) 2018 at 10:57 am cst stating that they had found one syringe (batch h218321n) that contained what appeared to be a hair within the syringe. What appeared to be a hair was caught prior to administration of the syringe contents to the patient. A photo of what appeared to be a hair was also received on the same day. The pharmacist communicated that the object did not move when the syringe was inverted. He further communicated that he peeled back the label to see if it was under the label and it was confirmed that it was not under the label. On august 24, 2018 at 10:30 am, medefil received the syringe with what appeared to be a hair in it. On august 24, 2018 at 12:00 pm, the qc laboratory evaluated syringe contaminant using a 100x microscope at a 10x and 40x magnification and it was confirmed to be a hair.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number1423982-2018-00003
MDR Report Key7815366
Report SourceHEALTH PROFESSIONAL
Date Received2018-08-24
Date of Report2018-11-20
Date of Event2018-08-20
Date Mfgr Received2018-08-20
Device Manufacturer Date2018-07-02
Date Added to Maude2018-08-24
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationOTHER HEALTH CARE PROFESSIONAL
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactMR. PRADEEP AGGARWAL
Manufacturer Street405 WINDY POINT DRIVE
Manufacturer CityGLENDALE HEIGHTS IL 60139
Manufacturer CountryUS
Manufacturer Postal60139
Manufacturer Phone6306814600
Manufacturer G1MEDEFIL, INC.
Manufacturer Street250 WINDY POINT DRIVE
Manufacturer CityGLENDALE HEIGHTS IL 60139
Manufacturer CountryUS
Manufacturer Postal Code60139
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameHEPARIN LOCK FLUSH SOLUTION, USP 2 USP UNIT/ 2 ML
Generic NameHEPARIN LOCK FLUSH SOLUTION, USP
Product CodeNZW
Date Received2018-08-24
Catalog NumberMIH-4422
Lot NumberH218312N
Device AvailabilityY
Device AgeDA
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerMEDEFIL, INC.
Manufacturer Address250 WINDY POINT DRIVE GLENDALE HEIGHTS IL 60139 US 60139


Patients

Patient NumberTreatmentOutcomeDate
10 2018-08-24

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.